TOP NEWS

Odonate Therapeutics Prices IPO

San Diego-based Odonate Therapeutics, a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share. The $24.00 per share was on the low end of its initial estimated pricing range of $24.00 to $27.00. The company is selling 6,250,000 shares of its common stock in the offering, which will raise $150M for the company. Odonate Therapeutics said it will trade on the NASDAQ Global Select Market as ODT, starting this morning. Odonate is backed by Tang Capital partners, Boxer Capital, Janus Capital Management, Sabby Management, Franklin Advisors, Solus, Arcus Venture Funds, Rock Springs Capital, and Samsara BioCapital.